Regulatory 2024-11-07 | Quarterly Report Q3: Successful Outcome from Rights Issue with SEK 105 Million Extends Runway Until Late 2025 PDF Report Presentation Webcast
Regulatory 2023-11-08 | QUARTERLY REPORT Q3 2023: Re-evaluation of SPARKLE Phase 3 Study Images Progresses According to Plan PDF Report Presentation Webcast
Regulatory 2022-11-04 | QUARTERLY REPORT Q3 2022: Successful completion of two out of three studies for regulatory submission PDF Report Presentation Webcast
Regulatory 2021-11-04 | Quarterly Report Q3 2021: Oncoral – entering clinical collaboration PDF Report Presentation Webcast
Regulatory 2020-11-05 | Quarterly Report Q3-2020: Raised market estimate for Mangoral and preparing for market launch PDF Report Presentation Webcast
